Category: Critical Care & Surgery / Organ Dysfunction
Chronic allograft nephropathy (CAN), now often referred to as chronic active antibody-mediated rejection or interstitial fibrosis and tubular atrophy, is a progressive decline in kidney transplant function over months to years, characterized by fibrosis and inflammation.
Affects 50-70% of kidney transplant recipients by 10 years post-transplant (Source: Kidney International, 2018).
Discover the latest clinical trials and treatments for Chronic Allograft Nephropathy on JourneyForHealth.
View Full Analysis